US$ 25.50
aspirin and glp 1 GLP-1 Agents vs Aspirin: A New Era in Colorectal Cancer Prevention Dr Jones on the Rationale
Description
Session Information Date: Sunday, October 26, 2025 Title: (04300469) Rheumatoid Arthritis Diagnosis, Manifestations, and Outcomes Poster I Session Type: Poster Session A Session Time: 10:30AM-12:30PM Background/Purpose: Obesity significantly increases cardiovascular morbidity and mortality in rheumatoid arthritis (RA), yet effective strategies for managing obesity-related risks in this population remain limited

10.1124/pr.108.000604 51 KimuraI.IchimuraA.Ohue-KitanoR.IgarashiM

GLP-1 drugs have revolutionized the way we treat Type 2 diabetes and obesity

Liraglutide reduces both atherosclerosis and kidney inflammation in moderately uremic LDLr-/- Mice

They may suggest treatment to manage the symptoms and advise whether it's safe to continue the medication .

One approach may be to taper off GLP-1s rather than quitting all at once
